Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2013 - 2026)

Ionis Pharmaceuticals' Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $661000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 74.45% year-over-year to $661000.0; the TTM figure through Mar 2026 stood at $8.3 million (up 146.91% YoY), while the FY2025 annual figure was $10.2 million, up 2.06% from the prior year.
• Amortizatization of Intangibles was $661000.0 for Q1 2026 at Ionis Pharmaceuticals, down from $3.4 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $10.4 million in Q2 2025 to a low of -$17.3 million in Q3 2024.
• Historically, Amortizatization of Intangibles has averaged $1.4 million across 5 years, with a median of $2.6 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles surged 805.9% in 2022, then sank 2716.06% in 2024.
• A 5-year view of Amortizatization of Intangibles shows it stood at -$9.2 million in 2022, then surged by 184.22% to $7.7 million in 2023, then gained by 5.42% to $8.2 million in 2024, then slumped by 57.81% to $3.4 million in 2025, then tumbled by 80.81% to $661000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $661000.0 (Q1 2026), $3.4 million (Q4 2025), and -$6.2 million (Q3 2025), per Business Quant data.